SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-296806
Filing Date
2021-10-12
Accepted
2021-10-12 15:16:11
Documents
13
Period of Report
2021-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d401899d8k.htm   iXBRL 8-K 43477
2 EX-10.1 d401899dex101.htm EX-10.1 109770
  Complete submission text file 0001193125-21-296806.txt   307419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20211009.xsd EX-101.SCH 2899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20211009_lab.xml EX-101.LAB 18841
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20211009_pre.xml EX-101.PRE 11844
6 EXTRACTED XBRL INSTANCE DOCUMENT d401899d8k_htm.xml XML 3563
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 211318445
SIC: 2835 In Vitro & In Vivo Diagnostic Substances